tiprankstipranks
Talis Biomedical (TLIS)
NASDAQ:TLIS
US Market

Talis Biomedical (TLIS) Financial Statements

41 Followers

Talis Biomedical Financial Overview

Talis Biomedical's market cap is currently ―. The company's EPS TTM is $-31.435; its P/E ratio is -0.27; Talis Biomedical is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 73.00K$ 76.00K--$ 257.00K
Gross Profit$ 67.00K$ 70.00K$ -7.00K$ -20.00K$ -6.89M
EBIT$ -13.04M$ -16.97M$ -15.03M$ -17.83M$ -26.93M
EBITDA$ -12.77M$ -16.75M$ -14.87M$ -17.66M$ -23.37M
Net Income Common Stockholders$ -13.04M$ -15.68M$ -15.03M$ -17.83M$ -26.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 70.34M$ 88.00M$ 99.21M$ 113.97M$ 130.19M
Total Assets$ 82.49M$ 107.23M$ 123.08M$ 133.05M$ 169.29M
Total Debt$ 19.24M$ 20.08M$ 20.38M$ 14.71M$ 33.58M
Net Debt$ -51.10M$ -67.91M$ -78.83M$ -99.26M$ -96.61M
Total Liabilities$ 25.81M$ 25.67M$ 26.91M$ 22.93M$ 42.55M
Stockholders Equity$ 56.68M$ 81.56M$ 96.17M$ 110.12M$ 126.74M
Cash Flow-
Free Cash Flow$ -6.40M$ -11.21M$ -14.76M$ -16.49M$ -13.59M
Operating Cash Flow$ -6.43M$ -11.14M$ -14.27M$ -16.46M$ -13.54M
Investing Cash Flow$ 30.00K$ -70.00K$ -485.00K$ -24.00K$ -49.00K
Financing Cash Flow$ 2.00K--$ 33.00K-
Currency in USD

Talis Biomedical Earnings and Revenue History

Talis Biomedical Debt to Assets

Talis Biomedical Cash Flow

Talis Biomedical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis